Zhifei Biological Products, the 2018 Richest Drug Maker in China

Zhifei Biological Products, the 2018 Richest Drug Maker in China


Merck & Co, developer of Gardasil and Gardasil 9 which recently got approved by Chinese authorities, have earned millions of dollars for their Zhifei Biological Products. It has also spurred two Chinese families into Bloomberg’s ranking of the world richest people. 
Jiang Rensheng, chairman of Zhifei Biological Products, boasted a net worth of about $4.6 billion on Wednesday as share price puffed-up the value of his stakes, according to reports it has helped him to achieve the 41st richest in China and 415th on the worldwide in Bloomberg Billionaires Index and the brand new pharmaceutical drugs entrepreneur to manage growing the company into the ranks of the world's richest.
Last May, when Gardasil cleared local regulatory review the company has witnessed its stock price more than double from about 20 Chinese yuan ($3) to more than 46 yuan Wednesday, just a few weeks after the new version of Gardasil 9, laddered its own nod.
 Back in 2012 the company signed the deal with Merck Co and was the sole provider for the vaccine in China when Gardasil got approval. In an emendation of that deal, Zhifei Biological agreed to buy $85.6 million worth of Gardasil in 2017 and $ 217 million in 2018.
Revenues at Zhifei in the first quarter, skyrocketed more than fourfold to 838 million Yuan ($130.7 million) as the first full quarter it’s been selling Gardasil, while its profits payable to shareholders also leveled-up more than 330%.  At the same time, Merck also enjoyed 24% Gardasil franchise sales growth to $660 million.
Source:http://media.drugdu.com/latest-information/market-views/zhifei-biological-products-the-2018-richest-drug-maker-in-china.html?dtag=1001310072

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文